跳至主要内容
临床试验/EUCTR2005-002455-41-SE
EUCTR2005-002455-41-SE进行中(未招募)不适用

Clinical, morphological and biochemical effects of antioxidant treatment of patients with chronic hepatitis C.

Karolinska Institutet0 个研究点目标入组 30 人开始时间: 2005年12月20日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Chronic hepatitis C with high activity and liver damage (fibrosis stage >2, inflammation grade >2 and persistant increase in transaminases, ALAT >2). The patient should be non-responders to conventional therapy or reject therapy. Age > 20 years old.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Responders to conventional therapy. Low activity and mild liverdamage (fibrosis stage <2, inflammation grade <2), ongoing alcohol abuse, BMI >30, Pregnancy and lactation.

研究者

相似试验